Mustang Bio, Inc.
Pagina dedicata companiei Mustang Bio, Inc. listata cu simbolurile US.MBIO, US.MBIOc
Descriere companie
Mustang Bio, Inc. (http://www.mustangbio.com/) is a clinical-stage biopharmaceutical company. The Company is focused on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases. Its pipeline is focused on three core areas: gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies and CAR T therapies for solid tumors. Its products include MB-107 and MB-207 is Ex vivo Lentiviral Therapy for X-linked Severe Combined Immunodeficiency (XSCID). XSCID is a rare genetic immune system condition also known as bubble boy disease. Its MB-102 is a CD123 CAR T cell Program for blastic plasmacytoid dendritic cell neoplasm (BPDCN), acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Grafic actiuni companie